STSadiya Tanga

Sadiya Tanga

*This is an algorithmically generated author record based on publicly available information.

Sadiya Tanga has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Tunable naphthalimide-based fluorogenic intracellular nanoaggregates trigger ROS-mediated DNA damage and apoptosis in triple-negative breast cancer cells

    by Arpita Hota, Aakash Ravikant Likhar, Sadiya Tanga, Arkadeep Karmakar, Deepak Asthana, Basudeb Maji

    Naphthalimide homodimers with tailored linkers control aggregation in cells. Amino acid-linked dimers show strong intracellular aggregation, enhanced emission, ROS generation, DNA damage, apoptosis, and potent anticancer activity against TNBC.


  • Engineered Thermostable Chemically Responsive GlowCas9 System for Real‐Time Therapeutic Monitoring Applications

    by Arkadeep Karmakar, Arpita Hota, Sadiya Tanga, Vivek Kumar, Pallabi Das, Anitha Eswari S, Mala Thapa, Basudeb Maji

    Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein (Cas) has revolutionized gene therapy applications due to its ease of design and efficiency, albeit accompanied by off‐target effects. Spatiotemporally regulated Cas9 offers safer gene editing methods due to its lower off‐target mediated genotoxicities; however, probing the Cas9 in real time for assessing the delivery efficiency, gene editing timeframe, and spatial target information remains elusive. Here, we report an engineered Cas9 system, GlowCas9, that can be probed chemically in real‐time across all assay systems, including cell lysate, native gel, ex vivo, and in vivo. Importantly, we rationally engineered the Cas9 system to attain remarkable thermostability with enhanced gene editing activities. Besides its sensitive reporter and enhanced gene editing activity, the GlowCas9 system exhibits precision HDR‐based gene knock‐in ability in cells and significantly outperformed the WTCas9. Overall, we report a new thermostable engineered Sp Cas9 system for real‐time theratracking applications compatible with diverse assay formats, including live ex vivo and in vivo. This GlowCas9 system will add a new dimension of non‐invasive real‐time tracking in gene therapy development, both ex vivo and in vivo.

  • Engineered Thermostable Chemically Responsive GlowCas9 System for Real‐Time Therapeutic Monitoring Applications

    by Arkadeep Karmakar, Arpita Hota, Sadiya Tanga, Vivek Kumar, Pallabi Das, Anitha Eswari S, Mala Thapa, Basudeb Maji

    Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein (Cas) has revolutionized gene therapy applications due to its ease of design and efficiency, albeit accompanied by off‐target effects. Spatiotemporally regulated Cas9 offers safer gene editing methods due to its lower off‐target mediated genotoxicities; however, probing the Cas9 in real time for assessing the delivery efficiency, gene editing timeframe, and spatial target information remains elusive. Here, we report an engineered Cas9 system, GlowCas9, that can be probed chemically in real‐time across all assay systems, including cell lysate, native gel, ex vivo, and in vivo. Importantly, we rationally engineered the Cas9 system to attain remarkable thermostability with enhanced gene editing activities. Besides its sensitive reporter and enhanced gene editing activity, the GlowCas9 system exhibits precision HDR‐based gene knock‐in ability in cells and significantly outperformed the WTCas9. Overall, we report a new thermostable engineered Sp Cas9 system for real‐time theratracking applications compatible with diverse assay formats, including live ex vivo and in vivo. This GlowCas9 system will add a new dimension of non‐invasive real‐time tracking in gene therapy development, both ex vivo and in vivo.


  • Open Access

    Design and synthesis of nucleic acid nano-environment interactome-targeting small molecule PROTACs and their anticancer activity

    by Sadiya Tanga, Arkadeep Karmakar, Arpita Hota, Paramita Banerjee, Basudeb Maji

    Small molecule-based nucleic-acid interactome protein degradation through PROteolysis TArgeting Chimeras (PROTACs) is a relatively new modality in cellular interventions.